Cambridge, MA, United States of America

Samantha Laber

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The Broad Institute, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Samantha Laber: Innovator in Metabolic Disorder Treatments

Introduction

Samantha Laber is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of metabolic disorders through her innovative research and patent work. Her dedication to advancing medical science is evident in her focused efforts to develop effective treatment methods.

Latest Patents

Samantha holds a patent titled "Methods for Treating Metabolic Disorders by Targeting ADCY5." This patent represents her commitment to finding solutions for complex health issues that affect many individuals worldwide. With 1 patent to her name, she is making strides in the medical research community.

Career Highlights

Samantha Laber is affiliated with The Broad Institute, Inc., where she collaborates with leading scientists and researchers. Her work at this prestigious institution allows her to engage in groundbreaking research that has the potential to change lives.

Collaborations

Throughout her career, Samantha has worked alongside talented colleagues, including Melina Claussnitzer and Nasa Sinnott-Armstrong. These collaborations enhance her research and contribute to the collective knowledge in the field of metabolic disorders.

Conclusion

Samantha Laber's innovative work in treating metabolic disorders showcases her dedication to improving health outcomes. Her contributions to the scientific community are invaluable, and her ongoing research promises to lead to further advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…